In the majority of schizophrenia patients, administration of new atypical antipsychotics seemed to result in higher levels of patient satisfaction than did conventional drugs. This had a favourable effect on the patients' attitude to the new medication, which may improve compliance. More patients perceived benefits related to quality of life than to efficacy. Clinical improvement was an important, but not the sole, determinant of patient satisfaction with medication.

psychological trauma or only physical agression) and cognitive and psycho-affective variables.Otherwise, we found a statistical difference on immediate memory as far as the delay of examination was concerned.Furthermore, most of the cognitive dysfunctions were correlated with the severity of anxiety and depression. PTSD seemed also perturbing work capacity. The details of these data will be demonstrated.